Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Journal of Immunology

• Publication date

  1978-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 641343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis.

  1976cited by this paper
• Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice.

  1976cited by this paper
• The relative susceptibility of New Zealand black and CBA mice to infection with opportunistic fungal pathogens.

  1976cited by this paper
• Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.

  1976cited by this paper
• Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.

  1975cited by this paper
• Nonoxidative Fungicidal Mechanisms of Mammalian Granulocytes: Demonstration of Components with Candidacidal Activity in Human, Rabbit, and Guinea Pig Leukocytes

  1975cited by this paper
• Transfer of Adoptive Immunity to Tuberculosis in Mice

  1975cited by this paper
• Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.

  1974cited by this paper
• Immunological Responses to Candida albicans II. Amyloidosis in Mice Induced by Candidiasis

  1974cited by this paper
• Infection and Immunoglobulin Concentrations in Chediak-Higashi Mice

  1974cited by this paper
• Immunological Responses to Candida albicans I. Mouse-Thigh Lesion as a Model for Experimental Candidiasis

  1974cited by this paper
• Immune abnormalities associated with chronic mucocutaneous candidiasis.

  1973cited by this paper
• Oral Infections with Candida Albicans

  1973cited by this paper
• Antigen-Antibody Crossed Electrophoresis (Laurell) Applied to the Study of the Antigenic Structure of Candida albicans

  1971cited by this paper
• Role of Complement During Experimental Candida Infection in Mice

  1971cited by this paper
• Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer

  1971cited by this paper
• Distribution of Lysosomal Enzymes, Cationic Proteins, and Bactericidal Substances in Subcellular Fractions of Human Polymorphonuclear Leukocytes

  1971cited by this paper
• The effect of inoculum size on the immune response to BCG infection in mice.

  1971cited by this paper
• Chronic mucocutaneous candidiasis: model-building in cellular immunity.

  1971cited by this paper
• Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy.

  1970cited by this paper
• Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

  1969cited by this paper
• Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features.

  1968cited by this paper
• The occurrence of opportunistic fungus infections in a cancer hospital.

  1962cited by this paper

• Serum Antibody Profile during Colonization of the Mouse Gut by Candida albicans: Relevance for Protection during Systemic Infection.

  2017cites this paper
• Use of Candida-specific chicken egg yolk antibodies to inhibit the adhering of Candida to denture base materials: prevention of denture stomatitis.

  2016cites this paper
• Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis

  2013cites this paper
• B Cell-Deficient Mice Display Enhanced Susceptibility to Paracoccidioides brasiliensis Infection

  2013cites this paper
• In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).

  2008cites this paper
• Advances in combating fungal diseases: vaccines on the threshold

  2007cites this paper
• Toxicity to Candidaalbicansmediated by human serum and peripheral blood mononuclear cells

  2006cites this paper
• Toxicity to Candida albicans mediated by human serum and peripheral blood mononuclear cells.

  2006cites this paper
• Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity

  2005cites this paper
• Active and passive immunization against oral Candida albicans infection in a murine model.

  2005cites this paper
• Mice with disseminated candidiasis die of progressive sepsis.

  2005cites this paper
• Defining criteria for anti-mannan antibodies to protect against candidiasis.

  2005cites this paper
• Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis

  2004cites this paper
• Normal Host Defense during Systemic Candidiasis in Mannose Receptor-Deficient Mice

  2003cites this paper
• The pathophysiology and treatment of Candida sepsis

  2002cites this paper
• Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis1

  2001cites this paper
• Protective effect of Nocardia opaca lysozyme digest in experimental murine Candida albicans infections.

  2001cites this paper
• Complement activation in SCID and nude mice is related to severity of tissue inflammation in the Candida mastitis model.

  2000cites this paper
• The role of antibodies in protection against candidiasis.

  1998cites this paper
• Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?

  1998cites this paper
• Burn‐associated Candida albicans infection caused by CD30+ type 2 T cells

  1998cites this paper
• The Candida albicans phosphomannan complex in Candida-host interactions.

  1998cites this paper
• Killer antibodies in fungal infections.

  1998cites this paper
• Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies

  1997cites this paper
• Macrophages in resistance to candidiasis.

  1997cites this paper
• Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature?

  1997cites this paper
• Efecto del yoduro de potasio sobre la respuesta inmune en la esporotricosis

  1997cites this paper
• Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals.

  1997cites this paper
• Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs

  1997cites this paper
• B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.

  1996cites this paper
• Antibodies against Candida: potential therapeutics?

  1996cites this paper
• Induced resistance to Candida albicans in BALB/c mice during short-term immunosuppression with cyclophosphamide.

  1995cites this paper
• Humoral immune responses to systemic Candida albicans infection in inbred mouse strains

  1995cites this paper
• Mannan Adhesins of Candida albicans: Characterization and Pathogenetic Implications

  1995cites this paper
• Antibody immunity and invasive fungal infections

  1995cites this paper
• Antibody response that protects against disseminated candidiasis

  1995cites this paper
• Humoral and cellular immune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans.

  1994cites this paper
• Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?

  1994cites this paper
• Immunologic aspects of oral candidiasis.

  1994cites this paper
• Patient-derived phage antibody display library as a source of human recombinant antibodies to candidal hsp 90

  1994cites this paper
• Introduction to Candida

  1993cites this paper
• Stimulation of human B cells specific for Candida albicans for monoclonal antibody production.

  1992cites this paper
• The role of hsp90 in fungal infection.

  1992cites this paper
• Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice

  1992cites this paper
• Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells.

  1992cites this paper
• Host defense system interactions with Candida.

  1992cites this paper
• Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis

  1992cites this paper
• The 14th C. L. Oakley Lecture. Candida albicans HSP 90: link between protective and auto immunity.

  1992cites this paper
• Acquired immunity to systemic candidiasis in immunodeficient mice: role of antibody to heat-shock protein 90.

  1992cites this paper
• [Systemic candidiasis].

  1992cites this paper
• Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis.

  1991cites this paper
• Acquired immunity to systemic candidiasis in immunodeficient mice.

  1991cites this paper
• Elimination of Candida albicans from kidneys of mice during short-term systemic infections.

  1991cites this paper
• Alteration of humoral responses to Candida in HIV infection

  1990cites this paper
• Murine candidiasis: Cell‐mediated immune responses correlate directly with susceptibility and resistance to infection

  1990cites this paper
• Mucosal and systemic candidiasis in congenitally immunodeficient mice

  1990cites this paper
• What's new in the mechanisms of host resistance to Candida albicans infection?

  1990cites this paper
• Antigens and immune responses in Candida albicans infection

  1990cites this paper
• The diagnostic and therapeutic potential of a monoclonal antibody to the 60-kilodalton nuclear antigen of Candida albicans

  1989cites this paper
• Immune response in mice infected with Candida albicans in the mycelial form

  1989cites this paper
• Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice

  1989cites this paper
• Vaccines for the management of dermatophyte and superficial yeast infections.

  1989cites this paper
• Contribution of granulocytes and monocytes to resistance against experimental disseminatedCandida albicans infection

  1988cites this paper
• Role of Activated Macrophages in Resistance to Systemic Candidosis

  1988cites this paper
• Immunotherapy of systemic candidiasis

  1988cites this paper
• Candida and AIDS: evidence for protective antibody.

  1988cites this paper
• Murine candidiasis: Strain dependence of host responses after immunization

  1988cites this paper
• Nonspecific and Candida‐Specific Immune Responses in Mice Suppressed by Chronic Administration of Anti‐μ

  1988cites this paper
• Mouse candidiasis

  1987cites this paper
• Studies of the role of B-cells in the resistance of mice to experimental candidiasis.

  1987cites this paper
• Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex.

  1987cites this paper
• Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans.

  1987cites this paper
• Vaccines against fungal infections.

  1987cites this paper
• Variability in expression of cell surface antigens of Candida albicans during morphogenesis

  1986cites this paper
• Induction of the immune response suppression in mice inoculated with Candida albicans

  1986cites this paper
• Activites des immunostimulants sur la phagocytose et activites derivees

  1986cites this paper
• [Action of immunostimulants on phagocytosis and derivative actions].

  1986cites this paper
• Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans

  1986cites this paper
• Evidence for macrophage-mediated protection against lethal Candida albicans infection

  1986cites this paper
• Host-parasite relationship in opportunistic mycoses.

  1986cites this paper
• Host defenses against pathogenic fungi

  1986cites this paper
• Dissociation between cell-mediated immunity and acquired resistance in systemic murine candidiasis.

  1985cites this paper
• Pathological observations in experimental candida infection of sensitized guinea pigs

  1985cites this paper
• Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice

  1985cites this paper
• Studies on Phagocytosis and Microbicidal Activity of Monocytes in Children with Acute Leukemia.

  1985cites this paper
• Studies on defense mechanisms against Candida albicans infection in congenitally athymicnude (nu/nu) mice

  1984cites this paper
• Immunodeficient CBA/N mice respond effectively to Candida albicans.

  1984cites this paper
• Role of antibody in defence against murine candidosis.

  1984cites this paper
• Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody

  1984cites this paper
• Oral Candidiasis in Cancer Patients

  1984cites this paper
• Mécanismes de défense dans les mycoses profondes

  1984cites this paper
• Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice.

  1983cites this paper
• Immunity to fungal infections.

  1983cites this paper
• Resistance and susceptibility to infection in inbred murine strains. I. Variations in the response to thymic hormones in mice infected with Candida albicans.

  1983cites this paper
• Candida albicans-induced agglutinin and immunoglobulin E responses in mice

  1983cites this paper
• Immunopathology of Mycotic Infections

  1983cites this paper
• Systemic candidosis in silica-treated athymic and euthymic mice

  1983cites this paper
• Enhanced antibody responses induced by Candida albicans in mice

  1982cites this paper
• Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice.

  1982cites this paper
• Characterization of mouse antibody responses to Candida albicans

  1982cites this paper